Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc A Rodger

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Thrombosis and Haemostasis|January 20, 2021
"Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid SyndromeLeslie Skeith, Marc A Rodger, Shannon M Bates, et al.
Respiratory Medicine|November 26, 2003
Topical tetracaine prior to arterial puncture: a randomized, placebo-controlled clinical trialShawn D Aaron, Katherine L Vandemheen, Sheila A Naftel, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 5, 2002
The management of thrombophilia during pregnancy: a Canadian surveyMarc A Rodger, Marc Carrier, Erin Keely, et al.
Journal of Thrombosis and Haemostasis : JTH|December 25, 2019
Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolismSebastien Miranda, Junghyun Park, Grégoire Le Gal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2012
Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trialMarc A Rodger, Tim Ramsay, Martin MacKinnon, et al.
Thrombosis Research|March 12, 2004
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapyMarc A Rodger, Christine Gagné-Rodger, Heather E Howley, et al.
Thrombosis Research|November 14, 2006
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysisMarc Carrier, Greg A Knoll, Michael J Kovacs, et al.
BMC Medical Research Methodology|January 12, 2012
Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysisAlejandro Lazo-Langner, Marc A Rodger, Nicholas J Barrowman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?Philip S Wells, Josdalyne L Anderson, Marc A Rodger, et al.
Systematic Reviews|October 30, 2019
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocolFaizan Khan, Miriam Kimpton, Tobias Tritschler, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Thrombosis and Haemostasis|January 20, 2021
"Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid SyndromeLeslie Skeith, Marc A Rodger, Shannon M Bates, et al.
Respiratory Medicine|November 26, 2003
Topical tetracaine prior to arterial puncture: a randomized, placebo-controlled clinical trialShawn D Aaron, Katherine L Vandemheen, Sheila A Naftel, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|December 5, 2002
The management of thrombophilia during pregnancy: a Canadian surveyMarc A Rodger, Marc Carrier, Erin Keely, et al.
Journal of Thrombosis and Haemostasis : JTH|December 25, 2019
Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolismSebastien Miranda, Junghyun Park, Grégoire Le Gal, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 7, 2012
Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trialMarc A Rodger, Tim Ramsay, Martin MacKinnon, et al.
Thrombosis Research|March 12, 2004
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapyMarc A Rodger, Christine Gagné-Rodger, Heather E Howley, et al.
Thrombosis Research|November 14, 2006
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysisMarc Carrier, Greg A Knoll, Michael J Kovacs, et al.
BMC Medical Research Methodology|January 12, 2012
Comparing multiple competing interventions in the absence of randomized trials using clinical risk-benefit analysisAlejandro Lazo-Langner, Marc A Rodger, Nicholas J Barrowman, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 22, 2006
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?Philip S Wells, Josdalyne L Anderson, Marc A Rodger, et al.
Systematic Reviews|October 30, 2019
Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocolFaizan Khan, Miriam Kimpton, Tobias Tritschler, et al.
Pageof 11